Skip to main content

Advertisement

Log in

An MRI-Driven Practice: a New Perspective on MRI for the Evaluation of Adenocarcinoma of the Head of the Pancreas

  • SSAT Poster Presentation
  • Published:
Journal of Gastrointestinal Surgery

Abstract

Objectives

The purpose of the study was to describe the MRI-driven management of masses at the head of the pancreas.

Main outcome measures

The main outcome measure was tumor resectability.

Methods

A retrospective review of prospective radiographic diagnoses was undertaken.

Results

Between 2004 and 2008, we have treated 124 patients for a radiographic diagnosis of adenocarcinoma of the head of the pancreas. This diagnosis was correct in 96.0% of the time. MRI was 100% sensitive in determining resectability, 73.2–78.9% specific, and had an overall accuracy of 86.3–87.5%. MRI could detect venous and arterial involvement with 95% and 95.9% accuracy, respectively, and missed only six metastases.

Conclusion

MRI is a useful tool in the preoperative imaging of pancreatic head lesions that is highly sensitive and very specific for resectable disease. Prospective trials of MRI in this setting are indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326(7):455–465.

    Article  CAS  PubMed  Google Scholar 

  2. Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2008;206(5):833–846.

    Article  PubMed  Google Scholar 

  3. Sasson AR, Gulizia JM, Galva A, Anderson J, Thompson J. Pancreaticoduodenectomy for suspected malignancy: have advancements in radiographic imaging improved results? Am J Surg 2006;192(6):888–893.

    Article  PubMed  Google Scholar 

  4. Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 2005;29(4):438–445.

    Article  PubMed  Google Scholar 

  5. Wong JC, Lu DS. Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol 2008;6(12):1301–1308.

    Article  PubMed  Google Scholar 

  6. White R, Winston C, Gonen M, et al. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 2008;206(3):445–450.

    Article  PubMed  Google Scholar 

  7. Hochwald SN, Rofsky NM, Dobryansky M, Shamamian P, Marcus SG. Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma. J Gastrointest Surg 1999;3(5):506–511.

    Article  CAS  PubMed  Google Scholar 

  8. Lopez Hanninen E, Amthauer H, Hosten N, et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 2002;224(1):34–41.

    Google Scholar 

  9. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability—report of the Radiology Diagnostic Oncology Group. Radiology 1995;195(2):327–332.

    CAS  PubMed  Google Scholar 

  10. Schima W, Fugger R, Schober E, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol 2002;179(3):717–724.

    PubMed  Google Scholar 

  11. Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A. Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 2005;30(4):488–500

    Article  CAS  PubMed  Google Scholar 

  12. House MG, Yeo CJ, Cameron JL, et al. Predicting resectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg 2004;8(3):280–288.

    Article  PubMed  Google Scholar 

  13. Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 2006;13(8):1035–1046

    Article  PubMed  Google Scholar 

  14. Jimenez RE,Warshaw AL, Rattner DW, et al. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg 2000;135:409–414.

    Article  CAS  PubMed  Google Scholar 

  15. Pisters PWT, Lee JE, Vauthey JN, et al. Laparoscopy in the staging of pancreatic cancer. Br J Surg 2001;88:325–337.

    Article  CAS  PubMed  Google Scholar 

  16. Conlon KC, Dougherty E, Klimstra DS, et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 1996;223:134–140.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juan M. Sarmiento.

Additional information

This paper is the manuscript of a poster presentation at SSAT 2009 (DDW, Chicago, IL, USA).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tapper, E.B., Martin, D., Adsay, N.V. et al. An MRI-Driven Practice: a New Perspective on MRI for the Evaluation of Adenocarcinoma of the Head of the Pancreas. J Gastrointest Surg 14, 1292–1297 (2010). https://doi.org/10.1007/s11605-010-1221-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-010-1221-z

Keywords

Navigation